| HOME >> BIOLOGY >> TECHNOLOGY |
Ordinary share $ 11,929,689 10,374,298 11,939,107 11,857,447
CONSOLIDATED BALANCE SHEETS
U.S. dollars in thousands (except share and per share data)
June 30, December 31,
2008 2007
Unaudited
ASSETS
CURRENT ASSETS:
Cash and cash
equivalents.............................. $ 12,090 $ 13,590
Short-term bank
deposits................................ 114 112
Marketable
securities................................. 2,745 8,251
Other accounts receivable and prepaid
expenses.............. 311 297
Total current
assets................................. 15,260 22,250
LONG-TERM
INVESTMENTS.............................. 1,760 2,391
SEVERANCE PAY
FUND................................. 195 144
PROPERTY AND EQUIPMENT,
NET......................... 1,311 1,253
OTHER
ASSETS...................................... 115 -
Total assets
....................................... $ 18,641 $ 26,038
LIABILITIES AND SHAREHOLDERS' EQUITY
CURRENT LIABILITIES:
Current maturities of capital lease and of
long-term loan....... $ 112 $ 247
Trade
payables.................................... 506 516
Other accounts payable and
accruals...................... 915 1,102
Total current
liabilities.............................. 1,533 1,865
LONG-TERM LIABILITIES:
Long-term bank loan and cap
'/>"/>
| SOURCE Rosetta Genomics Ltd Copyright©2008 PR Newswire. All rights reserved |